Research
Hormonal
Tirzepatide resulted in significant decreases in systolic blood pressure of median -4.20 mmHg for 5 mg, -5.34 mmHg for 10 mg, and -5.77 mmHg for 15 mg.
Tirzepatide may be an effective treatment for reducing systolic blood pressure in patients.
StrongSupportsmedium confidence
tirzepatide resulted in significant decreases in systolic blood pressure of median -4.20 (95% confidence interval [CI] -5.17 to -3.23) mmHg for 5 mg, -5.34 (-6.31 to -4.37) mmHg for 10 mg, and -5.77 (-6.73 to -4.81) mmHg for 15 mg.
Why this rating
Based on the meta-analysis of randomized controlled trials.
Source
Effect of tirzepatide on blood pressure and lipids: A meta‐analysis of randomized controlled trials
Mehmet Kanbay et al. · Diabetes Obesity and Metabolism · 2023
Meta-analysisCited 47×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →